Business Description
PhoenixBio Co Ltd
ISIN : JP3803010002
Description
PhoenixBio Co Ltd conducts study services for drug discovery and early development. It provides outsourcing services for drug development. The Company uses PXB-Mouse to conduct the study. Its services include pharmacokinetics related test, safety test, hepatitis virus (HBV / HCV) related drug efficacy test.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.77 | |||||
| Equity-to-Asset | 0.66 | |||||
| Debt-to-Equity | 0.28 | |||||
| Debt-to-EBITDA | 4.31 | |||||
| Interest Coverage | 37.27 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 1.98 | |||||
| Beneish M-Score | 1.6 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 11.8 | |||||
| 3-Year Book Growth Rate | 1.7 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 47.52 | |||||
| 9-Day RSI | 46.22 | |||||
| 14-Day RSI | 46.61 | |||||
| 6-1 Month Momentum % | -5.32 | |||||
| 12-1 Month Momentum % | -14.43 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.26 | |||||
| Quick Ratio | 4.19 | |||||
| Cash Ratio | 3.43 | |||||
| Days Inventory | 250.35 | |||||
| Days Sales Outstanding | 59.86 | |||||
| Days Payable | 24.4 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -7.4 | |||||
| Shareholder Yield % | 4.36 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 67.48 | |||||
| Operating Margin % | 4.15 | |||||
| Net Margin % | 6.35 | |||||
| FCF Margin % | 14.79 | |||||
| ROE % | 7.23 | |||||
| ROA % | 3.88 | |||||
| ROIC % | 4.32 | |||||
| ROC (Joel Greenblatt) % | 12.26 | |||||
| ROCE % | 6.32 | |||||
| Years of Profitability over Past 10-Year | 4 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 17.19 | |||||
| PE Ratio without NRI | 19.68 | |||||
| Price-to-Owner-Earnings | 8.32 | |||||
| PS Ratio | 1 | |||||
| PB Ratio | 1.08 | |||||
| Price-to-Tangible-Book | 1.08 | |||||
| Price-to-Free-Cash-Flow | 6.1 | |||||
| Price-to-Operating-Cash-Flow | 5.82 | |||||
| EV-to-EBIT | 8.92 | |||||
| EV-to-EBITDA | 8.92 | |||||
| EV-to-Revenue | 0.58 | |||||
| EV-to-FCF | 3.89 | |||||
| Price-to-Projected-FCF | 2.61 | |||||
| Price-to-Graham-Number | 0.97 | |||||
| Price-to-Net-Current-Asset-Value | 1.6 | |||||
| Price-to-Net-Cash | 4.18 | |||||
| Earnings Yield (Greenblatt) % | 11.21 | |||||
| FCF Yield % | 13.83 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
PhoenixBio Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | 1,792.39 | ||
| EPS (TTM) (円) | 27.694 | ||
| Beta | 0.18 | ||
| Volatility % | 18.74 | ||
| 14-Day RSI | 46.61 | ||
| 14-Day ATR (円) | 9.061574 | ||
| 20-Day SMA (円) | 478.75 | ||
| 12-1 Month Momentum % | -14.43 | ||
| 52-Week Range (円) | 442 - 628 | ||
| Shares Outstanding (Mil) | 4.03 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
PhoenixBio Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
PhoenixBio Co Ltd Stock Events
| Event | Date | Price(円) | ||
|---|---|---|---|---|
| No Event Data | ||||
PhoenixBio Co Ltd Frequently Asked Questions
What is PhoenixBio Co Ltd(TSE:6190)'s stock price today?
The current price of TSE:6190 is 円476.00. The 52 week high of TSE:6190 is 円628.00 and 52 week low is 円442.00.
When is next earnings date of PhoenixBio Co Ltd(TSE:6190)?
The next earnings date of PhoenixBio Co Ltd(TSE:6190) is .
Does PhoenixBio Co Ltd(TSE:6190) pay dividends? If so, how much?
PhoenixBio Co Ltd(TSE:6190) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers